News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Experts
MoneyTalks: How and where to spot multibaggers, and a couple of fundie’s recommendations
News
ASX Small Caps Lunch Wrap: Who else is having trouble spelling things right today?
News
ASX Large Caps: Shares flat after strong jobs data and updates from miners; Telix tumbles 15pc on Q2 results
Tech
These tech and pharma stocks are looking to M&A to drive growth in global markets
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Health & Biotech
These were the best ASX biotechs as Health Care sprang back to life in FY23
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: ASX health stocks up as Avita Medical gets US FDA green light
News
ASX Large Caps: Energy stocks slump, but Telstra, Woolworths, QBE touch 12-month highs
Health & Biotech
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines
Health & Biotech
4D Medical’s technology disrupts century-old procedures AND makes over 90pc profit margin
News
ASX Large Caps: Shares jump after guidance upgrades by Origin, Judo and Transurban
Health & Biotech
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales
Health & Biotech
ScoPo’s (actually still Iain’s) Powerplays: ASX health sector falls, but several stocks on upward run
Health & Biotech
ScoPo’s (actually Iain’s) Powerplays: ASX health stocks fall, Neuren’s DAYBUE drug officially rolling out in US
News
ASX Large Caps: Shares slump on RBA minutes, BlackRock ditches its 60-40 investment strategy
News
ASX Large Caps: Aussie inflation finally eases; SBF charged with bribing Chinese officials
Health & Biotech
